We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$405M
AUM Growth
+$70.3M
Cap. Flow
+$64.9M
Cap. Flow %
16.02%
Top 10 Hldgs %
67.85%
Holding
119
New
33
Increased
19
Reduced
31
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 9.86%
2 Healthcare 7.64%
3 Consumer Discretionary 4.38%
4 Communication Services 3.04%
5 Industrials 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$436B
$100M 24.81%
+730,000
New +$100M
QQQ icon
2
CALL
Invesco QQQ Trust
QQQ
$436B
$55.1M 13.6%
+400,000
New +$55M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$52.8M 13.05%
375,000
-45,000
-11% -$6.23M
AAPL icon
4
CALL
Apple
AAPL
$4.97T
$28.8M 7.11%
800,000
+560,000
+233% +$20.7M
SPY icon
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$7.25M 1.79%
30,000
-120,000
-80% -$28.8M
MTSI icon
6
MACOM Technology Solutions
MTSI
$17.4B
$6.99M 1.73%
125,400
+109,200
+674% +$5.89M
BABA icon
7
Alibaba
BABA
$276B
$6.48M 1.6%
46,000
+35,000
+318% +$4.32M
HIMX
8
CALL
Himax Technologies
HIMX
$2.03B
$6.06M 1.5%
738,500
HIMX
9
Himax Technologies
HIMX
$2.03B
$5.82M 1.44%
710,000
-625,000
-47% -$4.78M
AXGN icon
10
Axogen
AXGN
$2.2B
$4.95M 1.22%
295,351
-4,210
-1% -$56.8K
LITE icon
11
Lumentum
LITE
$46.9B
$4.87M 1.2%
85,300
+10,000
+13% +$536K
META icon
12
Meta Platforms (Facebook)
META
$1.49T
$4.77M 1.18%
31,600
-1,700
-5% -$253K
ADMS
13
DELISTED
Adamas Pharmaceuticals
ADMS
$4.61M 1.14%
263,515
+28,000
+12% +$463K
SBBP
14
DELISTED
Strongbridge Biopharma plc.
SBBP
$4.06M 1%
567,896
-27,133
-5% -$125K
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$3.75M 0.92%
+40,000
New +$2.45M
DY icon
16
Dycom Industries
DY
$11.2B
$3.58M 0.88%
+40,000
New +$3.88M
AERI
17
DELISTED
Aerie Pharmaceuticals
AERI
$3.26M 0.8%
61,959
-23,000
-27% -$1.07M
NPTN
18
DELISTED
NEOPHOTONICS CORP
NPTN
$3.25M 0.8%
421,304
+317,804
+307% +$2.69M
JPM icon
19
JPMorgan Chase
JPM
$916B
$3.2M 0.79%
35,000
-1,550
-4% -$134K
NEXT icon
20
NextDecade
NEXT
$1.68B
$3.13M 0.77%
+303,000
New +$3.11M
MB
21
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$2.89M 0.71%
+106,300
New +$2.92M
EVBG
22
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.62M 0.65%
107,550
+23,700
+28% +$565K
AMZN icon
23
Amazon
AMZN
$2.44T
$2.54M 0.63%
52,500
-3,000
-5% -$143K
NTES icon
24
NetEase
NTES
$83B
$2.44M 0.6%
40,500
GTLS
25
DELISTED
Chart Industries
GTLS
$2.43M 0.6%
+70,000
New +$2.44M

Similar funds

Granite Point Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Granite Point Capital Management held 119 positions worth $405M, up 21% from $335M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Granite Point Capital Management deployed $64.9M of net new capital in Q2 2017, opening 33 new positions and adding to 19 existing holdings. Its largest new stake was Dycom Industries: 40,000 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tellurian Inc., an estimated $26.3M trimmed.

  • Granite Point Capital Management's largest Q2 2017 buy was Dycom Industries: 40,000 shares worth $3.58M.
  • Granite Point Capital Management added most to MACOM Technology Solutions in Q2 2017, an estimated $5.89M increase.
  • Granite Point Capital Management's biggest Q2 2017 reduction was Tellurian Inc., cutting an estimated $26.3M.
  • Granite Point Capital Management fully exited Wright Medical Group Inc in Q2 2017, selling an estimated $3.42M.
  • Granite Point Capital Management's ten largest holdings make up 68% of its $405M portfolio in Q2 2017.
  • Granite Point Capital Management opened 33 new positions and closed 19 in Q2 2017.
  • Granite Point Capital Management's portfolio value rose 21% quarter-over-quarter to $405M.

Based on Granite Point Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.